Clinical study published

BioGaia’s probiotic effective in treating abdominal pain in children

Zvi Weizman, Professor at the Pediatric Gastroenterology and Nutrition Unit, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel.

Tell us about the background for the study.
Stomach pain is common among children and often affects the child’s daily life, for example through anxiety and school absenteeism. As a pediatric gastroenterologist I often meet these children and since there hasn’t been any effective treatment, I and my research colleagues wanted to test a well documented probiotic.

What did the results show?
The study confirms earlier results with L. reuteri Protectis. The number of pain episodes was almost halved among the children supplemented with Protectis. The intensity of the pain was also significantly reduced in the probiotic group compared to placebo, and this effect persisted during the follow-up period.

What conclusions can you draw from the study?
According to the results, physicians facing the common and challenging problem of functional abdominal pain in children can suggest L. reuteri Protectis as an easy way to ­relieve pain intensity and reduce its frequency. Protectis is reliable, effective and has no side effects.

BioGaia year